IPRAWAR-L INHALER is a powerful combination inhaler that contains Ipratropium Bromide (an anticholinergic bronchodilator) and Levosalbutamol (a selective β2-agonist bronchodilator). This dual-action therapy is designed to provide rapid and sustained bronchodilation, making it highly effective for patients suffering from Asthma, COPD (Chronic Obstructive Pulmonary Disease), Chronic Bronchitis, and Emphysema. How It Works Levosalbutamol - Acts quickly on β2-receptors in the airway smooth muscles, relieving bronchospasm and easing breathing. Ipratropium Bromide - Blocks muscarinic receptors, preventing acetylcholine-induced bronchoconstriction and reducing mucus secretion.
Send Message